This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Guo JQ, Lin H, Kantarjian H, Talpaz M, Champlin R, Andreeff M, Glassman A, Arlinghaus RB . Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia 2002; 16: 2447–2453.
Rawer D, Borkhardt A, Wilda M, Kropf S, Kreuder J . Influence of stochastics on quantitative PCR in the detection of minimal residual disease. Leukemia 2003; in press.
Kaeda J, Chase A, Goldman JM . Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia. Acta Haematol 2002; 107: 64–75.
Faderl S, Talpaz M, Kantarjian HM, Estrov Z . Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making? Blood 1999; 93: 2755–2759.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arlinghaus, R., Lin, H., Kim, HW. et al. Response to Influence of stochastics on quantitative PCR in the detection of minimal residual disease by Rawer et al. Leukemia 17, 2528–2529 (2003). https://doi.org/10.1038/sj.leu.2403192
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403192
This article is cited by
-
Reply to Arlinghaus et al
Leukemia (2003)